Global Neuroscience Antibodies & Assays Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

By Product;

Consumables - Reagents[Media and Sera, Stains and Dyes, Fixatives, Buffers, Solvents, Enzymes, Proteins, and Peptides, Probes and Other Reagents], - Antibodies[Primary Antibodies and Secondary Antibodies], - Assay Kits, Instruments - Immunoassay Analyzers, Microplate Readers and Other Instruments.

By Technology;

Immunoassays/Immunochemistry - Enzyme-Linked Immunosorbent Assay (Elisa), Western Blotting and Other Immunoassay Technologies, Molecular Diagnostics , Clinical Chemistry and Other Technologies.

By Application;

Drug Discovery & Development , Research and In Vitro Diagnostics.

By End User;

Pharmaceutical & Biotechnology Companies , Academic & Research Institutes and Hospitals & Diagnostics Centers.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2020 - 2030).
Report ID: Rn681881454 Published Date: June, 2024 Updated Date: July, 2024

Introduction

Global Neuroscience Antibodies & Assays Market (USD Million), 2020 - 2030

In the year 2023, the Global Neuroscience Antibodies & Assays Market was valued at USD 2,962.30 million. The size of this market is expected to increase to USD 5,485.13 million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of 9.2%.

The global neuroscience antibodies and assays market is witnessing significant growth, driven by advancements in neuroscientific research and the increasing prevalence of neurological disorders worldwide. Neuroscience antibodies and assays play a pivotal role in understanding the complexities of the nervous system, aiding researchers in unraveling the mechanisms underlying various neurological conditions. With an expanding spectrum of applications, ranging from basic neuroscience research to drug discovery and development, the demand for specialized antibodies and assays continues to surge.

One of the primary drivers propelling the market is the continuous evolution of technology in neuroscience. Innovations in techniques such as immunohistochemistry, western blotting, and enzyme-linked immunosorbent assays (ELISA) have revolutionized the field, enabling researchers to achieve higher sensitivity and specificity in detecting target proteins. Moreover, the advent of multiplex assays and high-throughput screening platforms has expedited the pace of neuroscience research, facilitating the analysis of complex signaling pathways and protein interactions.

The escalating burden of neurological disorders, including Alzheimer's disease, Parkinson's disease, and multiple sclerosis, is fueling the demand for neuroscience antibodies and assays. As the global population ages and lifestyle factors contribute to the rise in neurodegenerative conditions, there is a growing urgency to develop effective diagnostic and therapeutic solutions. Neuroscience antibodies and assays serve as indispensable tools in biomarker discovery, disease diagnosis, and the evaluation of potential therapeutic targets, thus driving advancements in precision medicine for neurological disorders.

The market is witnessing increased investments in research and development activities by both public and private sectors, aimed at addressing the unmet needs in neurology. Collaborative initiatives among academia, pharmaceutical companies, and government agencies are fostering interdisciplinary approaches to tackle the complexities of the nervous system. As a result, the landscape of the global neuroscience antibodies and assays market is characterized by ongoing innovation, with a focus on developing novel biomarkers, enhancing assay sensitivity and specificity, and expanding the repertoire of research tools available to neuroscientists worldwide.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product
    2. Market Snapshot, By Technology
    3. Market Snapshot, By Application
    4. Market Snapshot, By End User
    5. Market Snapshot, By Region
  4. Global Neuroscience Antibodies & Assays Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Growing Investments in R&D Activities
        2. Rising Demand for Personalized Medicine
        3. Expanding Applications of Neuroscience Antibodies and Assays
      2. Restraints
        1. Stringent Regulatory Guidelines
        2. Limited Awareness and Accessibility in Developing Regions
        3. Ethical Concerns Regarding Animal Testing
      3. Opportunities
        1. Collaborative Initiatives among Pharmaceutical Companies and Research Institutes
        2. Emerging Markets in Asia-Pacific and Latin America
        3. Advancements in Proteomic and Genomic Technologies
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Neuroscience Antibodies & Assays Market, By Product, 2020 - 2030 (USD Million)
      1. Consumables
        1. Reagents
        2. Media and Sera
        3. Stains and Dyes
        4. Fixatives
        5. Buffers
        6. Solvents
        7. Enzymes, Proteins, and Peptides
        8. Probes
        9. Other Reagents
      2. Antibodies
        1. Primary Antibodies
        2. Secondary Antibodies
        3. Assay Kits
        4. Instruments
        5. Immunoassay Analyzers
        6. Microplate Readers
        7. Other Instruments
    2. Global Neuroscience Antibodies & Assays Market, By Technology, 2020 - 2030 (USD Million)
      1. Immunoassays/Immunochemistry
      2. Enzyme-Linked Immunosorbent Assay (Elisa)
      3. Western Blotting
      4. Other Immunoassay Technologies
      5. Molecular Diagnostics
      6. Clinical Chemistry
      7. Other Technologies
    3. Global Neuroscience Antibodies & Assays Market, By Application, 2020 - 2030 (USD Million)
      1. Drug Discovery & Development
      2. Research
      3. In Vitro Diagnostics
    4. Global Neuroscience Antibodies & Assays Market, By End User, 2020 - 2030 (USD Million)
      1. Pharmaceutical & Biotechnology Companies
      2. Academic & Research Institutes
      3. Hospitals & Diagnostics Centers
    5. Global Neuroscience Antibodies & Assays Market, By Geography, 2020 - 2030 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Thermo Fisher Scientific
      2. Abcam
      3. Bio-Rad
      4. Merck KGaA
      5. Cell Signaling Technology
      6. Genscript
      7. Rockland Immunochemicals
      8. BioLegend
      9. Santa Cruz Biotechnology
      10. Tecan
      11. F. Hoffmann-La Roche
      12. Siemens
  7. Analyst Views
  8. Future Outlook of the Market